Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Non-Interventional Study to Investigate the Effectiveness, Safety and Utilization of Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions (NIELS)

Trial Profile

Non-Interventional Study to Investigate the Effectiveness, Safety and Utilization of Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions (NIELS)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Aug 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Vismodegib (Primary)
  • Indications Basal cell cancer
  • Focus Therapeutic Use
  • Acronyms NIELS
  • Sponsors Roche

Most Recent Events

  • 01 Aug 2021 Results (n=66) assessing effectiveness with a special focus on duration of response (DOR), safety and utilization of vismodegib for treatment of locally advanced basal cell carcinoma, in daily practice in Germany, published in the Journal of the European Academy of Dermatology and Venereology.
  • 10 May 2019 Status changed from active, no longer recruiting to completed.
  • 02 Oct 2017 Planned End Date changed from 1 Mar 2019 to 31 Mar 2019.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top